Trial Profile
Study of Ingenol mebutate gel for the treatment of Bowen's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Bowen's disease; Carcinoma; Squamous cell cancer
- Focus Therapeutic Use
- 08 May 2018 New trial record.